Formation of P450 · P450 complexes and their effect on P450 function
Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzy...
Saved in:
Published in | Pharmacology & therapeutics (Oxford) Vol. 133; no. 3; pp. 299 - 310 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b(5). Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450 · P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450 · P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism. |
---|---|
AbstractList | Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b
5
. Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450•P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450•P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism. Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s responsible for foreign compound metabolism generally are localized in the endoplasmic reticulum of the liver, lung and small intestine. P450 enzymes do not act alone but require an interaction with other electron transfer proteins such as NADPH-cytochrome P450 reductase (CPR) and cytochrome b(5). Because P450s are localized in the endoplasmic reticulum with these and other ER-resident proteins, there is a potential for protein-protein interactions to influence P450 function. There has been increasing evidence that P450 enzymes form complexes in the ER, with compelling support that formation of P450 · P450 complexes can significantly influence their function. Our goal is to review the research supporting the formation of P450 · P450 complexes, their specificity, and how drug metabolism may be affected. This review describes the potential mechanisms by which P450s may interact, and provides evidence to support each of the possible mechanisms. Additionally, evidence for the formation of both heteromeric and homomeric P450 complexes are reviewed. Finally, direct physical evidence for P450 complex formation in solution and in membranes is summarized, and questions directing the future research of functional P450 interactions are discussed with respect to their potential impact on drug metabolism. |
Author | Reed, James R Backes, Wayne L |
Author_xml | – sequence: 1 givenname: James R surname: Reed fullname: Reed, James R organization: Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA – sequence: 2 givenname: Wayne L surname: Backes fullname: Backes, Wayne L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22155419$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkN1KwzAYhoNM3I_eguQGWr-kadOeCDI2FQZ6oOBZSPPjOtampJ3olXnulZk6nQofvAff-wPPFI0a1xiEMIGYAMkuNnG7lr7u18bLmAIhcTiA4ghNSM6LKHieRmgSJIk4TfMxmnbdBgAYA3qCxpSSNGWkmKDF0vla9pVrsLP4nqWAP973qlzdbs2r6bBsNA5blcfGWqN6HNxfFrtr1JA9RcdWbjtz9q0z9LhcPMxvotXd9e38ahWpMNZHKuUZlTkrM52bHBhoqTkvCKHMcLDclFwnOmG6UNRmpZU2Y0xbSTNSgi1NMkOX-952V9ZGK9P0Xm5F66ta-jfhZCX-f5pqLZ7di0gop4SwUJDvC5R3XeeNPWQJiAGt2IhftGJAK8IFtCF6_nf7EPxhmXwCpsJ7YA |
CitedBy_id | crossref_primary_10_1042_BCJ20170543 crossref_primary_10_1021_acs_biochem_7b01012 crossref_primary_10_1016_j_ymgme_2019_01_015 crossref_primary_10_1042_BJ20120636 crossref_primary_10_1074_jbc_M114_615443 crossref_primary_10_1016_j_abb_2020_108677 crossref_primary_10_1016_j_taap_2015_09_021 crossref_primary_10_1002_pro_3603 crossref_primary_10_3389_fphar_2023_1055991 crossref_primary_10_1124_dmd_121_000758 crossref_primary_10_1016_j_phytol_2021_10_006 crossref_primary_10_1080_07391102_2021_1925154 crossref_primary_10_1007_s40610_017_0053_y crossref_primary_10_1371_journal_pone_0202534 crossref_primary_10_3390_molecules27206870 crossref_primary_10_1016_j_tips_2021_09_004 crossref_primary_10_1016_j_pharmthera_2019_107414 crossref_primary_10_1124_dmd_114_057901 crossref_primary_10_1016_j_jinorgbio_2018_03_002 crossref_primary_10_3389_fphar_2024_1397288 crossref_primary_10_1097_MNM_0000000000000875 crossref_primary_10_1080_03602532_2016_1221961 crossref_primary_10_1016_j_cellsig_2020_109769 crossref_primary_10_1074_jbc_RA120_015911 crossref_primary_10_3390_ijms141224438 crossref_primary_10_1016_S1452_3981_23_14007_7 crossref_primary_10_1124_dmd_115_068569 crossref_primary_10_1124_dmd_115_067637 crossref_primary_10_18097_PBMC20156102176 crossref_primary_10_1124_dmd_112_046094 crossref_primary_10_1042_BJ20130398 crossref_primary_10_1021_acs_jpcb_6b10108 crossref_primary_10_1007_s11095_018_2548_5 crossref_primary_10_1021_tx500203s crossref_primary_10_1042_BJ20140787 crossref_primary_10_1016_j_bbapap_2017_06_007 crossref_primary_10_1021_acs_molpharmaceut_6b00920 crossref_primary_10_1042_BCJ20210269 crossref_primary_10_1016_j_bioelechem_2016_05_005 crossref_primary_10_1042_BCJ20190532 crossref_primary_10_1080_03602532_2020_1765792 crossref_primary_10_3390_ijms231911458 crossref_primary_10_1021_jacs_7b00663 crossref_primary_10_1042_BSR20171161 crossref_primary_10_1124_mol_115_098582 crossref_primary_10_1002_cbin_11564 crossref_primary_10_3389_fphar_2017_00028 crossref_primary_10_1124_dmd_115_068593 crossref_primary_10_1002_prp2_53 crossref_primary_10_1016_j_jinorgbio_2023_112325 crossref_primary_10_1016_j_abb_2021_108937 crossref_primary_10_1016_j_tplants_2014_11_002 crossref_primary_10_1016_j_tiv_2019_01_002 crossref_primary_10_1038_s41598_018_30195_1 crossref_primary_10_1073_pnas_1323369111 crossref_primary_10_1134_S0006350913030172 crossref_primary_10_1134_S1990750816010042 crossref_primary_10_1021_bi400422a crossref_primary_10_1093_gigascience_giab016 crossref_primary_10_1016_j_nucmedbio_2014_08_015 crossref_primary_10_1021_jacs_7b08750 crossref_primary_10_1038_srep17671 crossref_primary_10_1016_j_taap_2014_03_021 crossref_primary_10_1124_dmd_113_054627 crossref_primary_10_1111_febs_14129 crossref_primary_10_1155_2017_8210734 crossref_primary_10_1124_dmd_115_068981 crossref_primary_10_1021_acssynbio_2c00132 |
Cites_doi | 10.1016/0014-5793(80)80400-5 10.1124/dmd.107.018473 10.3109/00498258209038946 10.1006/abbi.1996.9859 10.1016/S0021-9258(17)35233-X 10.1016/S0021-9258(18)32132-X 10.1016/S0021-9258(19)73803-4 10.1016/S0300-9084(97)82528-X 10.1016/0304-4157(75)90006-4 10.1006/abbi.1995.1253 10.1016/j.bbabio.2009.12.008 10.1006/abbi.1996.0086 10.1016/S0021-9258(18)83427-5 10.1021/bi9514572 10.1021/bi00094a009 10.1016/0014-5793(86)80861-4 10.1016/S0021-9258(18)83341-5 10.1021/jm060706p 10.1016/0014-5793(93)81083-C 10.1006/bbrc.1995.2854 10.1016/0003-9861(72)90448-1 10.1124/dmd.110.034942 10.1124/dmd.109.026500 10.1021/bi7003476 10.1016/S0021-9258(18)34532-0 10.1016/0003-9861(82)90217-X 10.1021/bi061803n 10.2174/187231211794455253 10.1021/bi00032a003 10.1111/j.1432-1033.1985.tb09001.x 10.1086/429417 10.1016/0014-5793(90)81261-L 10.1146/annurev.bi.49.070180.001531 10.1016/0003-9861(87)90291-8 10.1016/0006-2952(86)90759-8 10.1006/abbi.1997.0125 10.1016/S0021-9258(18)34533-2 10.1006/abbi.2001.2574 10.1016/S0021-9258(17)43364-3 10.1006/abbi.1997.9995 10.1074/jbc.M109.076885 10.1007/978-1-4615-0667-6_53 10.1124/dmd.104.001578 10.1016/0003-9861(83)90045-0 10.1021/bi00175a017 10.1016/0006-291X(90)91373-Z 10.1124/dmd.105.006825 10.1073/pnas.1106632108 10.1021/bi00004a018 10.1073/pnas.90.7.2651 10.1074/jbc.275.4.2545 10.1016/S0021-9258(18)62872-8 10.1074/jbc.M301489200 10.1016/S0021-9258(19)56992-7 10.1016/0003-9861(79)90383-7 10.1016/0026-0495(71)90091-6 10.1021/bi00591a029 10.1021/bi980674a 10.1124/dmd.105.005538 10.1124/dmd.109.030155 10.1002/jbt.10052 10.1074/jbc.271.44.27438 10.1074/jbc.270.10.5014 10.1016/S0021-9258(19)85640-5 10.1016/j.abb.2004.12.008 10.1021/bi0477900 10.1021/bi00551a041 10.1021/bi0509346 10.1038/ng1300 10.1016/S0163-7258(02)00327-3 10.1016/0005-2736(80)90188-1 10.1016/0014-5793(90)81479-8 10.1016/S0021-9258(17)33349-5 10.1016/0006-291X(92)92372-5 |
ContentType | Journal Article |
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. 2011 Elsevier Inc. All rights reserved. 2011 |
Copyright_xml | – notice: Copyright © 2011 Elsevier Inc. All rights reserved. – notice: 2011 Elsevier Inc. All rights reserved. 2011 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.pharmthera.2011.11.009 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-016X |
EndPage | 310 |
ExternalDocumentID | 10_1016_j_pharmthera_2011_11_009 22155419 |
Genre | Journal Article Review Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: P42 ES013648 – fundername: NIEHS NIH HHS grantid: P42 ES013648-01A2 – fundername: NIEHS NIH HHS grantid: R01 ES004344-16A1 – fundername: NIEHS NIH HHS grantid: R01 ES004344 – fundername: NIEHS NIH HHS grantid: R01 ES004344-18 – fundername: NIEHS NIH HHS grantid: P42 ES013648-02 – fundername: NIEHS NIH HHS grantid: R01 ES004344-17 – fundername: National Institute of Environmental Health Sciences : NIEHS grantid: P42 ES013648-02 || ES – fundername: National Institute of Environmental Health Sciences : NIEHS grantid: R01 ES004344-18 || ES – fundername: National Institute of Environmental Health Sciences : NIEHS grantid: P42 ES013648-01A2 || ES – fundername: National Institute of Environmental Health Sciences : NIEHS grantid: R01 ES004344-16A1 || ES – fundername: National Institute of Environmental Health Sciences : NIEHS grantid: R01 ES004344-17 || ES |
GroupedDBID | --- --K --M .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABFNM ABMAC ABXDB ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AFFNX AFJKZ AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CGR CS3 CUY CVF DU5 EBS ECM EFJIC EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W K-O KOM L7B M34 M41 MO0 N9A NPM O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI WUQ Y6R ZGI ZXP ~G- AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c419t-c5762a84b6d8e8040dad7791124e70f7eb7d3d34d9c2f6bfaf644dfa261b0fbe3 |
ISSN | 0163-7258 |
IngestDate | Tue Sep 17 20:49:38 EDT 2024 Thu Sep 26 18:20:47 EDT 2024 Sat Sep 28 08:01:45 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright © 2011 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c419t-c5762a84b6d8e8040dad7791124e70f7eb7d3d34d9c2f6bfaf644dfa261b0fbe3 |
OpenAccessLink | https://europepmc.org/articles/pmc3272114?pdf=render |
PMID | 22155419 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3272114 crossref_primary_10_1016_j_pharmthera_2011_11_009 pubmed_primary_22155419 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmacology & therapeutics (Oxford) |
PublicationTitleAlternate | Pharmacol Ther |
PublicationYear | 2012 |
References | 1985961 - J Biol Chem. 1991 Jan 15;266(2):735-9 8218220 - Biochemistry. 1993 Nov 2;32(43):11530-8 4395592 - Metabolism. 1971 Feb;20(2):187-99 117825 - Biochemistry. 1979 Nov 27;18(24):5442-9 2495281 - J Biol Chem. 1989 Apr 15;264(11):6252-9 11717170 - Drug Metab Dispos. 2001 Dec;29(12):1529-34 4385007 - J Biol Chem. 1968 Mar 25;243(6):1331-2 19448135 - Drug Metab Dispos. 2009 Aug;37(8):1682-9 6769473 - Biochemistry. 1980 May 13;19(10):2260-4 6863312 - J Biol Chem. 1983 Jul 25;258(14):8839-47 9056240 - Arch Biochem Biophys. 1997 Mar 1;339(1):107-14 20215413 - Drug Metab Dispos. 2010 Jun;38(6):1003-9 7215544 - FEBS Lett. 1980 Dec 15;122(1):54-8 4650614 - Arch Biochem Biophys. 1972 Nov;153(1):298-303 6285833 - Arch Biochem Biophys. 1982 Jun;216(1):322-8 2168169 - Biochem Biophys Res Commun. 1990 Aug 31;171(1):175-81 14486217 - J Biol Chem. 1962 Aug;237:2652-60 15486075 - Drug Metab Dispos. 2005 Jan;33(1):157-64 17311370 - J Med Chem. 2007 Mar 22;50(6):1158-65 20071338 - J Biol Chem. 2010 Mar 19;285(12):8942-52 8319808 - FEBS Lett. 1993 Jul 5;325(3):251-4 12481306 - J Biochem Mol Toxicol. 2002;16(6):311-6 6421810 - J Biol Chem. 1984 Feb 25;259(4):2390-5 6806262 - J Biol Chem. 1982 Jun 25;257(12):7030-6 8634277 - Biochemistry. 1996 Feb 6;35(5):1466-74 7085615 - J Biol Chem. 1982 Jun 25;257(12):7023-9 7890608 - J Biol Chem. 1995 Mar 10;270(10):5014-8 3592665 - Arch Biochem Biophys. 1987 May 15;255(1):27-41 15980100 - Drug Metab Dispos. 2005 Sep;33(9):1382-90 17176103 - Biochemistry. 2006 Dec 26;45(51):15807-16 16229479 - Biochemistry. 2005 Oct 25;44(42):13902-13 16415125 - Drug Metab Dispos. 2006 Apr;34(4):660-6 9185616 - Arch Biochem Biophys. 1997 Jun 1;342(1):82-91 1417844 - Biochem Biophys Res Commun. 1992 Oct 15;188(1):216-21 15793702 - Am J Hum Genet. 2005 May;76(5):729-49 3743769 - FEBS Lett. 1986 Sep 1;205(1):35-40 17685587 - Biochemistry. 2007 Sep 4;46(35):10192-201 20699412 - Drug Metab Dispos. 2010 Nov;38(11):1976-83 7168192 - Xenobiotica. 1982 Nov;12(11):717-26 6311109 - Arch Biochem Biophys. 1983 Aug;225(1):398-404 1699791 - FEBS Lett. 1990 Sep 17;270(1-2):177-80 4018075 - Eur J Biochem. 1985 Jul 1;150(1):155-9 7733676 - Arch Biochem Biophys. 1995 Apr 20;318(2):446-56 18048487 - Drug Metab Dispos. 2008 Mar;36(3):582-8 7640265 - Biochemistry. 1995 Aug 15;34(32):10113-9 12559387 - Pharmacol Ther. 2003 Feb;97(2):139-52 112928 - Arch Biochem Biophys. 1979 Jul;195(2):565-77 10644712 - J Biol Chem. 2000 Jan 28;275(4):2545-53 8464872 - Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2651-5 6996566 - Annu Rev Biochem. 1980;49:315-56 9737863 - Biochemistry. 1998 Sep 15;37(37):12852-9 20026040 - Biochim Biophys Acta. 2010 Mar;1797(3):378-90 8117709 - Biochemistry. 1994 Mar 8;33(9):2484-9 9186495 - Arch Biochem Biophys. 1997 Jun 15;342(2):329-37 8910324 - J Biol Chem. 1996 Nov 1;271(44):27438-44 20942796 - Drug Metab Lett. 2011 Jan;5(1):6-16 11764964 - Adv Exp Med Biol. 2001;500:335-8 3790162 - Biochem Pharmacol. 1986 Dec 15;35(24):4431-6 2164629 - Mol Pharmacol. 1990 Jul;38(1):134-42 819436 - J Biol Chem. 1976 Jul 10;251(13):4010-6 6773567 - Biochim Biophys Acta. 1980 Jul;599(2):417-35 2261995 - FEBS Lett. 1990 Nov 26;275(1-2):235-8 15709776 - Biochemistry. 2005 Feb 22;44(7):2632-41 4393962 - J Biol Chem. 1970 Sep 25;245(18):4851-4 12766165 - J Biol Chem. 2003 Aug 15;278(33):31269-76 6768748 - J Biol Chem. 1980 May 10;255(9):4112-9 9010599 - Biochimie. 1996;78(8-9):706-13 173395 - Biochim Biophys Acta. 1975 Dec 29;415(4):411-72 4389465 - J Biol Chem. 1969 Jul 10;244(13):3714-21 8615680 - Arch Biochem Biophys. 1996 Mar 1;327(1):11-9 15680923 - Arch Biochem Biophys. 2005 Mar 1;435(1):207-16 7827074 - Biochemistry. 1995 Jan 31;34(4):1244-7 21808038 - Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13486-91 14758361 - Nat Genet. 2004 Mar;36(3):228-30 11673866 - Arch Biochem Biophys. 2001 Nov 1;395(1):57-68 8554612 - Biochem Biophys Res Commun. 1995 Dec 26;217(3):886-91 Lu (10.1016/j.pharmthera.2011.11.009_bb0190) 1968; 243 White (10.1016/j.pharmthera.2011.11.009_bb0355) 1980; 49 Yamazaki (10.1016/j.pharmthera.2011.11.009_bb0375) 1997; 342 Koley (10.1016/j.pharmthera.2011.11.009_bb0170) 1996; 78 French (10.1016/j.pharmthera.2011.11.009_bb0090) 1979; 195 Wagner (10.1016/j.pharmthera.2011.11.009_bb0345) 1984; 259 Pernecky (10.1016/j.pharmthera.2011.11.009_bb0235) 1995; 318 Yamada (10.1016/j.pharmthera.2011.11.009_bb0370) 1995; 34 Locuson (10.1016/j.pharmthera.2011.11.009_bb0180) 2007; 50 Peterson (10.1016/j.pharmthera.2011.11.009_bb0240) 1976; 251 Dong (10.1016/j.pharmthera.2011.11.009_bb0075) 1996; 327 Kelley (10.1016/j.pharmthera.2011.11.009_bb0155) 2006; 45 Wood (10.1016/j.pharmthera.2011.11.009_bb0360) 1983; 258 Subramanian (10.1016/j.pharmthera.2011.11.009_bb0315) 2010; 38 Causey (10.1016/j.pharmthera.2011.11.009_bb0025) 1990; 38 McIntosh (10.1016/j.pharmthera.2011.11.009_bb0200) 1980; 122 Davydov (10.1016/j.pharmthera.2011.11.009_bb0065) 2010; 1797 von Wachenfeldt (10.1016/j.pharmthera.2011.11.009_bb0340) 1997; 339 Xia (10.1016/j.pharmthera.2011.11.009_bb0365) 2011; 108 Gibson (10.1016/j.pharmthera.2011.11.009_bb0100) 1986; 35 Davydov (10.1016/j.pharmthera.2011.11.009_bb0055) 1992; 188 Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0220) 1993; 325 Reed (10.1016/j.pharmthera.2011.11.009_bb0260) 2011; 5 Estabrook (10.1016/j.pharmthera.2011.11.009_bb0080) 1971; 20 Loida (10.1016/j.pharmthera.2011.11.009_bb0185) 1993; 32 Viner (10.1016/j.pharmthera.2011.11.009_bb0335) 1995; 217 Ozalp (10.1016/j.pharmthera.2011.11.009_bb0225) 2005; 33 Szczesna-Skorupa (10.1016/j.pharmthera.2011.11.009_bb0320) 2003; 278 Schwarz (10.1016/j.pharmthera.2011.11.009_bb0285) 1982; 216 Koley (10.1016/j.pharmthera.2011.11.009_bb0175) 1994; 33 Cosme (10.1016/j.pharmthera.2011.11.009_bb0040) 2000; 275 Cawley (10.1016/j.pharmthera.2011.11.009_bb0030) 1995; 34 Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0215) 1990; 270 Shimada (10.1016/j.pharmthera.2011.11.009_bb0295) 2005; 435 Baskin (10.1016/j.pharmthera.2011.11.009_bb0020) 1980; 19 Reed (10.1016/j.pharmthera.2011.11.009_bb0265) 2010; 285 Scott (10.1016/j.pharmthera.2011.11.009_bb0290) 2001; 395 Phillips (10.1016/j.pharmthera.2011.11.009_bb0245) 1962; 237 Cawley (10.1016/j.pharmthera.2011.11.009_bb0035) 2001; 29 Subramanian (10.1016/j.pharmthera.2011.11.009_bb0310) 2009; 37 Reed (10.1016/j.pharmthera.2011.11.009_bb0270) 2006; 34 Gut (10.1016/j.pharmthera.2011.11.009_bb0115) 1982; 257 Kawato (10.1016/j.pharmthera.2011.11.009_bb0150) 1982; 257 Davydov (10.1016/j.pharmthera.2011.11.009_bb0045) 2005; 44 West (10.1016/j.pharmthera.2011.11.009_bb0350) 1972; 153 Depierre (10.1016/j.pharmthera.2011.11.009_bb0070) 1975; 415 Jamakhandi (10.1016/j.pharmthera.2011.11.009_bb0140) 2007; 46 Pernecky (10.1016/j.pharmthera.2011.11.009_bb0230) 1993; 90 Guengerich (10.1016/j.pharmthera.2011.11.009_bb0110) 1979; 18 Sonderfan (10.1016/j.pharmthera.2011.11.009_bb0300) 1987; 255 Flück (10.1016/j.pharmthera.2011.11.009_bb0085) 2004; 36 Schwarz (10.1016/j.pharmthera.2011.11.009_bb0280) 1990; 171 Hu (10.1016/j.pharmthera.2011.11.009_bb0125) 2010; 38 Davydov (10.1016/j.pharmthera.2011.11.009_bb0060) 2001; 500 Huang (10.1016/j.pharmthera.2011.11.009_bb0130) 2005; 76 Strobel (10.1016/j.pharmthera.2011.11.009_bb0305) 1970; 245 Tan (10.1016/j.pharmthera.2011.11.009_bb0325) 1997; 342 Davydov (10.1016/j.pharmthera.2011.11.009_bb0050) 1985; 150 Kelley (10.1016/j.pharmthera.2011.11.009_bb0160) 2005; 44 Backes (10.1016/j.pharmthera.2011.11.009_bb0015) 1989; 264 Greinert (10.1016/j.pharmthera.2011.11.009_bb0105) 1982; 12 Miller (10.1016/j.pharmthera.2011.11.009_bb0205) 1996; 35 Porter (10.1016/j.pharmthera.2011.11.009_bb0250) 2002; 16 Reed (10.1016/j.pharmthera.2011.11.009_bb0255) 2008; 36 Ingelman-Sundberg (10.1016/j.pharmthera.2011.11.009_bb0135) 1980; 599 Tsuprun (10.1016/j.pharmthera.2011.11.009_bb0330) 1986; 205 Kaminsky (10.1016/j.pharmthera.2011.11.009_bb0145) 1983; 225 Koley (10.1016/j.pharmthera.2011.11.009_bb0165) 1995; 270 Alston (10.1016/j.pharmthera.2011.11.009_bb0005) 1991; 266 Backes (10.1016/j.pharmthera.2011.11.009_bb0010) 1998; 37 Lu (10.1016/j.pharmthera.2011.11.009_bb0195) 1969; 244 Myasoedova (10.1016/j.pharmthera.2011.11.009_bb0210) 1990; 275 Yamazaki (10.1016/j.pharmthera.2011.11.009_bb0380) 1996; 271 French (10.1016/j.pharmthera.2011.11.009_bb0095) 1980; 255 Hazai (10.1016/j.pharmthera.2011.11.009_bb0120) 2005; 33 Schenkman (10.1016/j.pharmthera.2011.11.009_bb0275) 2003; 97 |
References_xml | – volume: 122 start-page: 54 year: 1980 ident: 10.1016/j.pharmthera.2011.11.009_bb0200 article-title: Evidence from cross-linking and rotational diffusion studies that cytochrome P450 can from molecular aggregates in rabbit-liver microsomal membranes publication-title: FEBS Lett doi: 10.1016/0014-5793(80)80400-5 contributor: fullname: McIntosh – volume: 36 start-page: 582 year: 2008 ident: 10.1016/j.pharmthera.2011.11.009_bb0255 article-title: Physical incorporation of NADPH–cytochrome P450 reductase and cytochrome P450 into phospholipid vesicles using glycocholate and Bio-Beads publication-title: Drug Metab Dispos doi: 10.1124/dmd.107.018473 contributor: fullname: Reed – volume: 12 start-page: 717 year: 1982 ident: 10.1016/j.pharmthera.2011.11.009_bb0105 article-title: Cytochrome P-450 rotamers control mixed-function oxygenation in reconstituted membranes. Rotational diffusion studied by delayed fluorescence depolarization publication-title: Xenobiotica doi: 10.3109/00498258209038946 contributor: fullname: Greinert – volume: 339 start-page: 107 year: 1997 ident: 10.1016/j.pharmthera.2011.11.009_bb0340 article-title: Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus publication-title: Arch Biochem Biophys doi: 10.1006/abbi.1996.9859 contributor: fullname: von Wachenfeldt – volume: 266 start-page: 735 year: 1991 ident: 10.1016/j.pharmthera.2011.11.009_bb0005 article-title: Interactions among cytochromes P-450 in the endoplasmic reticulum. Detection of chemically cross-linked complexes with monoclonal antibodies publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)35233-X contributor: fullname: Alston – volume: 258 start-page: 8839 year: 1983 ident: 10.1016/j.pharmthera.2011.11.009_bb0360 article-title: Regio- and stereoselective metabolism of two C19-steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)32132-X contributor: fullname: Wood – volume: 237 start-page: 2652 year: 1962 ident: 10.1016/j.pharmthera.2011.11.009_bb0245 article-title: Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)73803-4 contributor: fullname: Phillips – volume: 78 start-page: 706 year: 1996 ident: 10.1016/j.pharmthera.2011.11.009_bb0170 article-title: Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics publication-title: Biochimie doi: 10.1016/S0300-9084(97)82528-X contributor: fullname: Koley – volume: 415 start-page: 411 year: 1975 ident: 10.1016/j.pharmthera.2011.11.009_bb0070 article-title: Structural aspects of the membrane of the endoplasmic reticulum publication-title: Biochim Biophys Acta doi: 10.1016/0304-4157(75)90006-4 contributor: fullname: Depierre – volume: 318 start-page: 446 year: 1995 ident: 10.1016/j.pharmthera.2011.11.009_bb0235 article-title: Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli publication-title: Arch Biochem Biophys doi: 10.1006/abbi.1995.1253 contributor: fullname: Pernecky – volume: 1797 start-page: 378 year: 2010 ident: 10.1016/j.pharmthera.2011.11.009_bb0065 article-title: Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium publication-title: Biochim Biophys Acta doi: 10.1016/j.bbabio.2009.12.008 contributor: fullname: Davydov – volume: 327 start-page: 11 year: 1996 ident: 10.1016/j.pharmthera.2011.11.009_bb0075 article-title: Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH–cytochrome P450 reductase publication-title: Arch Biochem Biophys doi: 10.1006/abbi.1996.0086 contributor: fullname: Dong – volume: 244 start-page: 3714 year: 1969 ident: 10.1016/j.pharmthera.2011.11.009_bb0195 article-title: Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)83427-5 contributor: fullname: Lu – volume: 35 start-page: 1466 year: 1996 ident: 10.1016/j.pharmthera.2011.11.009_bb0205 article-title: X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes publication-title: Biochemistry doi: 10.1021/bi9514572 contributor: fullname: Miller – volume: 32 start-page: 11530 year: 1993 ident: 10.1016/j.pharmthera.2011.11.009_bb0185 article-title: Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions publication-title: Biochemistry doi: 10.1021/bi00094a009 contributor: fullname: Loida – volume: 205 start-page: 35 year: 1986 ident: 10.1016/j.pharmthera.2011.11.009_bb0330 article-title: Quaternary structure of the liver microsomal cytochrome P-450 publication-title: FEBS Lett doi: 10.1016/0014-5793(86)80861-4 contributor: fullname: Tsuprun – volume: 264 start-page: 6252 year: 1989 ident: 10.1016/j.pharmthera.2011.11.009_bb0015 article-title: Cytochrome P-450 LM2 reduction. Substrate effects on the rate of reductase–LM2 association publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)83341-5 contributor: fullname: Backes – volume: 50 start-page: 1158 year: 2007 ident: 10.1016/j.pharmthera.2011.11.009_bb0180 article-title: Use of simple docking methods to screen a virtual library for heteroactivators of cytochrome P450 2C9 publication-title: J Med Chem doi: 10.1021/jm060706p contributor: fullname: Locuson – volume: 325 start-page: 251 year: 1993 ident: 10.1016/j.pharmthera.2011.11.009_bb0220 article-title: Cytochrome P-450: hexameric structure of the purified LM4 form publication-title: FEBS Lett doi: 10.1016/0014-5793(93)81083-C contributor: fullname: Myasoedova – volume: 217 start-page: 886 year: 1995 ident: 10.1016/j.pharmthera.2011.11.009_bb0335 article-title: Effect of different solubilizing agents on the aggregation state and catalytic activity of two purified rabbit cytochrome p450 isozymes, CYP1A2(LM4) and CYP2B4(LM2) publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1995.2854 contributor: fullname: Viner – volume: 153 start-page: 298 year: 1972 ident: 10.1016/j.pharmthera.2011.11.009_bb0350 article-title: Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. V. Competition between cytochromes P-450 and P-448 for reductase in 3,4-benzpyrene hydroxylation publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(72)90448-1 contributor: fullname: West – volume: 38 start-page: 1976 year: 2010 ident: 10.1016/j.pharmthera.2011.11.009_bb0125 article-title: CYP2C8 exists as a dimer in natural membranes publication-title: Drug Metab Dispos doi: 10.1124/dmd.110.034942 contributor: fullname: Hu – volume: 37 start-page: 1682 year: 2009 ident: 10.1016/j.pharmthera.2011.11.009_bb0310 article-title: CYP2D6–CYP2C9 protein–protein interactions and isoform-selective effects on substrate binding and catalysis publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.026500 contributor: fullname: Subramanian – volume: 46 start-page: 10192 year: 2007 ident: 10.1016/j.pharmthera.2011.11.009_bb0140 article-title: Global analysis of protein–protein interactions reveals multiple CYP2E1-reductase complexes publication-title: Biochemistry doi: 10.1021/bi7003476 contributor: fullname: Jamakhandi – volume: 257 start-page: 7023 year: 1982 ident: 10.1016/j.pharmthera.2011.11.009_bb0150 article-title: Rotation of cytochrome P-450. I. Investigations of protein–protein interactions of cytochrome P-450 in phospholipid vesicles and liver microsomes publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)34532-0 contributor: fullname: Kawato – volume: 216 start-page: 322 year: 1982 ident: 10.1016/j.pharmthera.2011.11.009_bb0285 article-title: Rotational diffusion of cytochrome P-450 in the microsomal membrane-evidence for a clusterlike organization from saturation transfer electron paramagnetic resonance spectroscopy publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(82)90217-X contributor: fullname: Schwarz – volume: 45 start-page: 15807 year: 2006 ident: 10.1016/j.pharmthera.2011.11.009_bb0155 article-title: Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions publication-title: Biochemistry doi: 10.1021/bi061803n contributor: fullname: Kelley – volume: 5 start-page: 6 year: 2011 ident: 10.1016/j.pharmthera.2011.11.009_bb0260 article-title: Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes publication-title: Drug Metab Lett doi: 10.2174/187231211794455253 contributor: fullname: Reed – volume: 34 start-page: 10113 year: 1995 ident: 10.1016/j.pharmthera.2011.11.009_bb0370 article-title: Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH–cytochrome P450 reductase in proteoliposomes publication-title: Biochemistry doi: 10.1021/bi00032a003 contributor: fullname: Yamada – volume: 150 start-page: 155 year: 1985 ident: 10.1016/j.pharmthera.2011.11.009_bb0050 article-title: Kinetic studies on reduction of cytochromes P-450 and b5 by dithionite publication-title: Eur J Biochem doi: 10.1111/j.1432-1033.1985.tb09001.x contributor: fullname: Davydov – volume: 76 start-page: 729 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0130 article-title: Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis publication-title: Am J Hum Genet doi: 10.1086/429417 contributor: fullname: Huang – volume: 270 start-page: 177 year: 1990 ident: 10.1016/j.pharmthera.2011.11.009_bb0215 article-title: Immobilized cytochrome P-450LM2. Dissociation and reassociation of oligomers publication-title: FEBS Lett doi: 10.1016/0014-5793(90)81261-L contributor: fullname: Myasoedova – volume: 49 start-page: 315 year: 1980 ident: 10.1016/j.pharmthera.2011.11.009_bb0355 article-title: Oxygen activation by cytochrome P-450 publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.49.070180.001531 contributor: fullname: White – volume: 255 start-page: 27 year: 1987 ident: 10.1016/j.pharmthera.2011.11.009_bb0300 article-title: Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450 publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(87)90291-8 contributor: fullname: Sonderfan – volume: 35 start-page: 4431 year: 1986 ident: 10.1016/j.pharmthera.2011.11.009_bb0100 article-title: Incorporation of cytochrome b5 into rat liver microsomal membranes. Impairment of cytochrome P-450-dependent mixed function oxidase activity publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(86)90759-8 contributor: fullname: Gibson – volume: 342 start-page: 329 year: 1997 ident: 10.1016/j.pharmthera.2011.11.009_bb0375 article-title: Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450–P450 and cytochrome P450–b5 interactions publication-title: Arch Biochem Biophys doi: 10.1006/abbi.1997.0125 contributor: fullname: Yamazaki – volume: 257 start-page: 7030 year: 1982 ident: 10.1016/j.pharmthera.2011.11.009_bb0115 article-title: Rotation of cytochrome P-450. II. Specific interactions of cytochrome P-450 with NADPH–cytochrome P-450 reductase in phospholipid vesicles publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)34533-2 contributor: fullname: Gut – volume: 395 start-page: 57 year: 2001 ident: 10.1016/j.pharmthera.2011.11.009_bb0290 article-title: A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function publication-title: Arch Biochem Biophys doi: 10.1006/abbi.2001.2574 contributor: fullname: Scott – volume: 259 start-page: 2390 year: 1984 ident: 10.1016/j.pharmthera.2011.11.009_bb0345 article-title: Effect of a zwitterionic detergent on the state of aggregation and catalytic activity of cytochrome P-450LM2 and NADPH–cytochrome P-450 reductase publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)43364-3 contributor: fullname: Wagner – volume: 342 start-page: 82 year: 1997 ident: 10.1016/j.pharmthera.2011.11.009_bb0325 article-title: Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH–cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system publication-title: Arch Biochem Biophys doi: 10.1006/abbi.1997.9995 contributor: fullname: Tan – volume: 285 start-page: 8942 year: 2010 ident: 10.1016/j.pharmthera.2011.11.009_bb0265 article-title: Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation publication-title: J Biol Chem doi: 10.1074/jbc.M109.076885 contributor: fullname: Reed – volume: 500 start-page: 335 year: 2001 ident: 10.1016/j.pharmthera.2011.11.009_bb0060 article-title: Association of cytochromes P450 1A2 and 2B4: are the interactions between different P450 species involved in the control of the monooxygenase activity and coupling? publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-0667-6_53 contributor: fullname: Davydov – volume: 33 start-page: 157 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0120 article-title: Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze methoxychlor demethylation in human liver microsomes publication-title: Drug Metab Dispos doi: 10.1124/dmd.104.001578 contributor: fullname: Hazai – volume: 225 start-page: 398 year: 1983 ident: 10.1016/j.pharmthera.2011.11.009_bb0145 article-title: Comparisons of warfarin metabolism by liver microsomes of rats treated with a series of polybrominated biphenyl congeners and by the component-purified cytochrome P-450 isozymes publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(83)90045-0 contributor: fullname: Kaminsky – volume: 33 start-page: 2484 year: 1994 ident: 10.1016/j.pharmthera.2011.11.009_bb0175 article-title: Kinetics of CO binding to cytochromes P450 in the endoplasmic reticulum publication-title: Biochemistry doi: 10.1021/bi00175a017 contributor: fullname: Koley – volume: 171 start-page: 175 year: 1990 ident: 10.1016/j.pharmthera.2011.11.009_bb0280 article-title: Membrane topology of microsomal cytochrome P-450: saturation transfer EPR and freeze-fracture electron microscopy studies publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(90)91373-Z contributor: fullname: Schwarz – volume: 34 start-page: 660 year: 2006 ident: 10.1016/j.pharmthera.2011.11.009_bb0270 article-title: An evaluation of methods for the reconstitution of cytochromes P450 and NADPH P450 reductase into lipid vesicles publication-title: Drug Metab Dispos doi: 10.1124/dmd.105.006825 contributor: fullname: Reed – volume: 108 start-page: 13486 year: 2011 ident: 10.1016/j.pharmthera.2011.11.009_bb0365 article-title: Structural basis for human NADPH–cytochrome P450 oxidoreductase deficiency publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1106632108 contributor: fullname: Xia – volume: 34 start-page: 1244 year: 1995 ident: 10.1016/j.pharmthera.2011.11.009_bb0030 article-title: Substrate-dependent competition of different P450 isozymes for limiting NADPH–cytochrome P450 reductase publication-title: Biochemistry doi: 10.1021/bi00004a018 contributor: fullname: Cawley – volume: 90 start-page: 2651 year: 1993 ident: 10.1016/j.pharmthera.2011.11.009_bb0230 article-title: Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 in Escherichia coli: influence of NH2-terminal region on localization in cytosol and membranes publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.90.7.2651 contributor: fullname: Pernecky – volume: 275 start-page: 2545 year: 2000 ident: 10.1016/j.pharmthera.2011.11.009_bb0040 article-title: Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding publication-title: J Biol Chem doi: 10.1074/jbc.275.4.2545 contributor: fullname: Cosme – volume: 245 start-page: 4851 year: 1970 ident: 10.1016/j.pharmthera.2011.11.009_bb0305 article-title: Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)62872-8 contributor: fullname: Strobel – volume: 278 start-page: 31269 year: 2003 ident: 10.1016/j.pharmthera.2011.11.009_bb0320 article-title: Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells publication-title: J Biol Chem doi: 10.1074/jbc.M301489200 contributor: fullname: Szczesna-Skorupa – volume: 243 start-page: 1331 year: 1968 ident: 10.1016/j.pharmthera.2011.11.009_bb0190 article-title: Role of hemoprotein P-450 in fatty acid omega-hydroxylation in a soluble enzyme system from liver microsomes publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)56992-7 contributor: fullname: Lu – volume: 195 start-page: 565 year: 1979 ident: 10.1016/j.pharmthera.2011.11.009_bb0090 article-title: Properties of NADPH–cytochrome P-450 reductase purified from rabbit liver microsomes publication-title: Arch Biochem Biophys doi: 10.1016/0003-9861(79)90383-7 contributor: fullname: French – volume: 20 start-page: 187 year: 1971 ident: 10.1016/j.pharmthera.2011.11.009_bb0080 article-title: Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control publication-title: Metabolism doi: 10.1016/0026-0495(71)90091-6 contributor: fullname: Estabrook – volume: 18 start-page: 5442 year: 1979 ident: 10.1016/j.pharmthera.2011.11.009_bb0110 article-title: Hydrodynamic characterization of highly purified and functionally active liver microsomal cytochrome P-450 publication-title: Biochemistry doi: 10.1021/bi00591a029 contributor: fullname: Guengerich – volume: 37 start-page: 12852 year: 1998 ident: 10.1016/j.pharmthera.2011.11.009_bb0010 article-title: Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4–1A2 complex with a high affinity for NADPH–cytochrome P450 reductase publication-title: Biochemistry doi: 10.1021/bi980674a contributor: fullname: Backes – volume: 33 start-page: 1382 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0225 article-title: Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH–cytochrome p450 reductase molecular interactions in living cells publication-title: Drug Metab Dispos doi: 10.1124/dmd.105.005538 contributor: fullname: Ozalp – volume: 38 start-page: 1003 year: 2010 ident: 10.1016/j.pharmthera.2011.11.009_bb0315 article-title: CYP2C9–CYP3A4 protein–protein interactions in a reconstituted expressed enzyme system publication-title: Drug Metab Dispos doi: 10.1124/dmd.109.030155 contributor: fullname: Subramanian – volume: 38 start-page: 134 year: 1990 ident: 10.1016/j.pharmthera.2011.11.009_bb0025 article-title: Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2-dependent activities publication-title: Mol Pharmacol contributor: fullname: Causey – volume: 16 start-page: 311 year: 2002 ident: 10.1016/j.pharmthera.2011.11.009_bb0250 article-title: The roles of cytochrome b5 in cytochrome P450 reactions publication-title: J Biochem Mol Toxicol doi: 10.1002/jbt.10052 contributor: fullname: Porter – volume: 271 start-page: 27438 year: 1996 ident: 10.1016/j.pharmthera.2011.11.009_bb0380 article-title: Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4 — characterization of a reconstituted cytochrome P450 3A4 NADPH–cytochrome P450 reductase system and studies with apo-cytochrome b5 publication-title: J Biol Chem doi: 10.1074/jbc.271.44.27438 contributor: fullname: Yamazaki – volume: 270 start-page: 5014 year: 1995 ident: 10.1016/j.pharmthera.2011.11.009_bb0165 article-title: CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers publication-title: J Biol Chem doi: 10.1074/jbc.270.10.5014 contributor: fullname: Koley – volume: 255 start-page: 4112 year: 1980 ident: 10.1016/j.pharmthera.2011.11.009_bb0095 article-title: Interactions of cytochrome P-450, NADPH–cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)85640-5 contributor: fullname: French – volume: 435 start-page: 207 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0295 article-title: Interactions of mammalian cytochrome P450, NADPH–cytochrome P450 reductase, and cytochrome b(5) enzymes publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2004.12.008 contributor: fullname: Shimada – volume: 29 start-page: 1529 year: 2001 ident: 10.1016/j.pharmthera.2011.11.009_bb0035 article-title: Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations publication-title: Drug Metab Dispos contributor: fullname: Cawley – volume: 44 start-page: 2632 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0160 article-title: Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2 publication-title: Biochemistry doi: 10.1021/bi0477900 contributor: fullname: Kelley – volume: 19 start-page: 2260 year: 1980 ident: 10.1016/j.pharmthera.2011.11.009_bb0020 article-title: Cross-linking studies of cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase publication-title: Biochemistry doi: 10.1021/bi00551a041 contributor: fullname: Baskin – volume: 44 start-page: 13902 year: 2005 ident: 10.1016/j.pharmthera.2011.11.009_bb0045 article-title: Kinetics of dithionite-dependent reduction of cytochrome P450 3A4: heterogeneity of the enzyme caused by its oligomerization publication-title: Biochemistry doi: 10.1021/bi0509346 contributor: fullname: Davydov – volume: 36 start-page: 228 year: 2004 ident: 10.1016/j.pharmthera.2011.11.009_bb0085 article-title: Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome publication-title: Nat Genet doi: 10.1038/ng1300 contributor: fullname: Flück – volume: 97 start-page: 139 year: 2003 ident: 10.1016/j.pharmthera.2011.11.009_bb0275 article-title: The many roles of cytochrome b5 publication-title: Pharmacol Ther doi: 10.1016/S0163-7258(02)00327-3 contributor: fullname: Schenkman – volume: 599 start-page: 417 year: 1980 ident: 10.1016/j.pharmthera.2011.11.009_bb0135 article-title: Incorporation of purified components of the rabbit liver microsomal hydroxylase system into phospholipid vesicles publication-title: Biochim Biophys Acta doi: 10.1016/0005-2736(80)90188-1 contributor: fullname: Ingelman-Sundberg – volume: 275 start-page: 235 year: 1990 ident: 10.1016/j.pharmthera.2011.11.009_bb0210 article-title: Cytochrome P-450LM2 oligomers in proteoliposomes publication-title: FEBS Lett doi: 10.1016/0014-5793(90)81479-8 contributor: fullname: Myasoedova – volume: 251 start-page: 4010 year: 1976 ident: 10.1016/j.pharmthera.2011.11.009_bb0240 article-title: Temperature dependence of cytochrome P-450 reduction. A model for NADPH–cytochrome P-450 reductase:cytochrome P-450 interaction publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)33349-5 contributor: fullname: Peterson – volume: 188 start-page: 216 year: 1992 ident: 10.1016/j.pharmthera.2011.11.009_bb0055 article-title: High pressure induced inactivation of ferrous cytochrome P-450 LM2 (IIB4) CO complex: evidence for the presence of two conformers in the oligomer publication-title: Biochem Biophys Res Commun doi: 10.1016/0006-291X(92)92372-5 contributor: fullname: Davydov |
SSID | ssj0004402 |
Score | 2.3760655 |
SecondaryResourceType | review_article |
Snippet | Cytochromes P450 (P450) are membrane-bound enzymes that catalyze the monooxygenation of a diverse array of xenobiotic and endogenous compounds. The P450s... |
SourceID | pubmedcentral crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 299 |
SubjectTerms | Animals Binding, Competitive Cytochrome P-450 Enzyme System - chemistry Cytochrome P-450 Enzyme System - metabolism Humans NADPH-Ferrihemoprotein Reductase - metabolism |
Title | Formation of P450 · P450 complexes and their effect on P450 function |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22155419 https://pubmed.ncbi.nlm.nih.gov/PMC3272114 |
Volume | 133 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZ4LCyIN-UlD7QLpGodtw4jICqEACFUJLbIjs8CJEoFRQIG_hY7v4yznacoErAkUWK7yX2Xy_n63ZmQbQZa7xndCRQTOuCS8yBiMglsiAG9W-hExuYOn513j6_4yXXnuljmzmWXjFQzeRubV_IfVPEc4mqzZP-AbD4onsBjxBe3iDBuf4VxL8s8dEw23mnt1A9Z_UD4Y8cWhxd4yliSt48pfcP-Q-Ca2K9ajkzqol4Uxaw9m6aUouVCtD7HsBRCuAQfMXWM2xIDUaKF8CQ--Yq-7Gk5wmCpGhnFqgneKkbCkqrckoOF2fQFLFL9CMtG0C959M04-zjBXXNon8Pduy-haquotipdUMzDewcaY9bhSa1qtTB2dmmSTDO0Mta8Nd8Lfg8vqFue0Df-Z2016HSgimuS-yNVrmzJ-ejPkdl01kD3vQrMkwkYLJBGitTrLu2XINqlDVrGcJEc5XpCHwy1wNPPD7_PdYSijlCnI9TrCMXWrkmmI0vkqnfUPzwO0uUzggQfZhQkOJVkMuKqqyOI0FhrqYXAjxvjIFpGgBI61CHXewkzXWWkQd9YG4lzatUyCsJlMjV4GMAqChGA67ZI2kkX32F8fdGxAylVCAL7g6qRdia5eOirpMQZffAuLgQfW8HjpDNGwdfIipds3iPDoUZEReZ5A1sKvXplcHvjSqKHzEYy-NqPY66TmUK1N8jU6PEZNtGdHKktpzZfJUZzYQ |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Formation+of+P450+%C2%B7+P450+complexes+and+their+effect+on+P450+function&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Reed%2C+James+R&rft.au=Backes%2C+Wayne+L&rft.date=2012-03-01&rft.eissn=1879-016X&rft.volume=133&rft.issue=3&rft.spage=299&rft_id=info:doi/10.1016%2Fj.pharmthera.2011.11.009&rft_id=info%3Apmid%2F22155419&rft.externalDocID=22155419 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-7258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-7258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-7258&client=summon |